THE Australian Self-Medication
Industry has reassured consumers
taking low-dose NSAIDs for short
term pain relief that the medicines
are safe when used as directed.
ASMI has issued a statement after
new research published in The
Lancet which found some NSAIDs
increased the risk of adverse events
- but those were taken at high
doses for extended periods.The above article was sent to subscribers in Pharmacy Daily's issue from 31 May 13 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 31 May 13
MONTU Group, its subsidiary Alternaleaf Pty Ltd, and their common director Christopher Strauch are facing legal action by the Therapeutic Goods Administration (TGA) in the Federal Court of Australia for alleged unlawful advertising on the effectiveness of their medicinal cannabis products.
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.